UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-01, Vol.28 (1), p.71-80

2022

Volltextzugriff (PDF)

Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer

Journal of antimicrobial chemotherapy, 2023-05, Vol.78 (5), p.1253-1258

2023

Volltextzugriff (PDF)

Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction

Gene therapy, 2011-05, Vol.18 (5), p.479-487

2011

Volltextzugriff (PDF)

A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer

Gene therapy, 2014-09, Vol.21 (9), p.828-839

2014

Volltextzugriff (PDF)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-10, Vol.28 (10), p.2217-2217

2022

Volltextzugriff (PDF)

Gene therapy for the Wiskott-Aldrich syndrome

Current opinion in allergy and clinical immunology, 2011-12, Vol.11 (6), p.545-550

2011

Volltextzugriff (PDF)

The intravenous vancomycin prescription practices of French infectious disease specialists: A cross-sectional observational study

Infectious diseases now (Online), 2022-10, Vol.52 (7), p.414-417

2022

Volltextzugriff (PDF)

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Gene therapy, 2007-03, Vol.14 (5), p.415-428

2007

Volltextzugriff (PDF)

Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease

Gene therapy, 2011-11, Vol.18 (11), p.1087-1097

2011

Volltextzugriff (PDF)

Like Angler Fish, CAARs Lure Their Prey

Molecular therapy, 2016-08, Vol.24 (8), p.1339-1341

Galy, Anne

2016

Volltextzugriff (PDF)

Major Advances in the Development of Vectors for Clinical Gene Therapy of Hematopoietic Stem Cells from European Groups over the Last 25 Years

Human gene therapy, 2017-11, Vol.28 (11), p.964-971

Galy, Anne

2017

Volltextzugriff (PDF)

A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice

Gene therapy, 2005-04, Vol.12 (7), p.597-606

2005

Volltextzugriff (PDF)

Lymphopoiesis in transgenic mice over-expressing Artemis

Gene therapy, 2016-02, Vol.23 (2), p.176-186

2016

Volltextzugriff (PDF)

Gene therapy on the move

EMBO molecular medicine, 2013-11, Vol.5 (11), p.1642-1661

2013

Volltextzugriff (PDF)

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

Science (American Association for the Advancement of Science), 2013-08, Vol.341 (6148), p.865-865

2013

Volltextzugriff (PDF)

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

Blood, 2017-09, Vol.130 (11), p.1327-1335

2017

Volltextzugriff (PDF)

Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients

Blood, 2017-09, Vol.130 (13), p.1535-1542

2017

Volltextzugriff (PDF)

Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells

The Journal of biological chemistry, 2016-01, Vol.291 (5), p.2161-2169

2016

Volltextzugriff (PDF)

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application

Human gene therapy, 2011-03, Vol.22 (3), p.343-356

2011

Volltextzugriff (PDF)

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing

Human gene therapy, 2019-12, Vol.30 (12), p.1477-1493

2019

Volltextzugriff (PDF)

Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo

PloS one, 2014-07, Vol.9 (7), p.e101644-e101644

2014

Volltextzugriff (PDF)

Simultaneous Analysis of Secondary Structure and Light Scattering from Circular Dichroism Titrations: Application to Vectofusin-1

Scientific reports, 2016-12, Vol.6 (1), p.39450-39450, Article 39450

2016

Volltextzugriff (PDF)

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice

Molecular therapy, 2016-11, Vol.24 (11), p.1965-1973

2016

Volltextzugriff (PDF)

The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling

Haematologica (Roma), 2011-10, Vol.96 (10), p.1415-1423

2011

Volltextzugriff (PDF)

MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV

Molecular therapy, 2012-08, Vol.20 (8), p.1571-1581

2012

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(253)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(175)
Humans
(105)
Animals
(53)
Male
(47)
Immunology
(45)
Female
(42)
Gene Therapy
(42)
Human Health And Pathology
(36)
Medicine, Research & Experimental
(35)
Research & Experimental Medicine
(35)
Cellular Biology
(31)
Biochemistry & Molecular Biology
(28)
Cell Biology
(28)
Biotechnology & Applied Microbiology
(27)
Mice
(27)
Adult
(26)
Biological And Medical Sciences
(26)
Genetics & Heredity
(24)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gene Therapy
(9)
Molecular Therapy
(9)
Plos One
(8)
Blood
(7)
Human Gene Therapy
(7)
Molecular Therapy. Methods & Clinical Development
(6)
Biology Of Sport
(4)
Gene Ther
(4)
Haematologica
(4)
Nature Medicine
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer

Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction

A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Gene therapy for the Wiskott-Aldrich syndrome

The intravenous vancomycin prescription practices of French infectious disease specialists: A cross-sectional observational study

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease

Like Angler Fish, CAARs Lure Their Prey

Major Advances in the Development of Vectors for Clinical Gene Therapy of Hematopoietic Stem Cells from European Groups over the Last 25 Years

A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice

Lymphopoiesis in transgenic mice over-expressing Artemis

Gene therapy on the move

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients

Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing

Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo

Simultaneous Analysis of Secondary Structure and Light Scattering from Circular Dichroism Titrations: Application to Vectofusin-1

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice

The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling

MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV

Aktive Filter

Suchergebnisse filtern